PL1866338T3 - Przeciwciała przeciwko cd38 do leczenia szpiczaka mnogiego - Google Patents

Przeciwciała przeciwko cd38 do leczenia szpiczaka mnogiego

Info

Publication number
PL1866338T3
PL1866338T3 PL06722861T PL06722861T PL1866338T3 PL 1866338 T3 PL1866338 T3 PL 1866338T3 PL 06722861 T PL06722861 T PL 06722861T PL 06722861 T PL06722861 T PL 06722861T PL 1866338 T3 PL1866338 T3 PL 1866338T3
Authority
PL
Poland
Prior art keywords
treatment
antibodies against
multiple myeloma
myeloma
antibodies
Prior art date
Application number
PL06722861T
Other languages
English (en)
Polish (pl)
Inventor
Michel De Weers
Yvo Graus
Judith Oprins
Paul Parren
Jan Van De Winkel
Vugt Martine Van
Original Assignee
Genmab A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genmab A/S filed Critical Genmab A/S
Priority claimed from EP06722861.9A external-priority patent/EP1866338B1/en
Publication of PL1866338T3 publication Critical patent/PL1866338T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL06722861T 2005-03-23 2006-03-23 Przeciwciała przeciwko cd38 do leczenia szpiczaka mnogiego PL1866338T3 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DKPA200500429 2005-03-23
US66757905P 2005-04-01 2005-04-01
US69616305P 2005-07-01 2005-07-01
US72856105P 2005-10-20 2005-10-20
EP06722861.9A EP1866338B1 (en) 2005-03-23 2006-03-23 Antibodies against cd38 for treatment of multiple myeloma

Publications (1)

Publication Number Publication Date
PL1866338T3 true PL1866338T3 (pl) 2017-04-28

Family

ID=50644285

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06722861T PL1866338T3 (pl) 2005-03-23 2006-03-23 Przeciwciała przeciwko cd38 do leczenia szpiczaka mnogiego

Country Status (12)

Country Link
KR (1) KR20140033240A (enExample)
BE (1) BE2017C062I2 (enExample)
DK (1) DK1866338T3 (enExample)
ES (2) ES2644982T3 (enExample)
HU (2) HUE030783T2 (enExample)
LT (2) LT2567976T (enExample)
NZ (2) NZ600059A (enExample)
PL (1) PL1866338T3 (enExample)
PT (2) PT2567976T (enExample)
RS (1) RS55442B1 (enExample)
SG (1) SG10201610317VA (enExample)
UA (2) UA98756C2 (enExample)

Also Published As

Publication number Publication date
ES2606762T3 (es) 2017-03-27
LT2567976T (lt) 2017-12-11
KR20140033240A (ko) 2014-03-17
NZ625944A (en) 2016-01-29
UA98756C2 (ru) 2012-06-25
RS55442B1 (sr) 2017-04-28
DK1866338T3 (da) 2017-01-02
HUE030783T2 (en) 2017-06-28
HUE034962T2 (en) 2018-03-28
BE2017C062I2 (enExample) 2025-12-03
LT1866338T (lt) 2017-01-25
SG10201610317VA (en) 2017-02-27
UA116520C2 (uk) 2018-04-10
PT1866338T (pt) 2016-12-14
PT2567976T (pt) 2017-10-19
ES2644982T3 (es) 2017-12-01
NZ600059A (en) 2016-01-29

Similar Documents

Publication Publication Date Title
IL304150A (en) Antibodies against 38cd for the treatment of multiple myeloma
HRP20181565T1 (hr) Monoklonska protutijela protiv klaudina-18 za liječenje karcinoma
PL2029155T3 (pl) Ulepszony sposób leczenia szpiczaka mnogiego
IL243687A0 (en) For the treatment of multiple myeloma 1–cs antibodies against
PT1962913E (pt) Radioimunoconjugado para cd66 humano para o tratamento de mieloma múltiplo
HUS1700054I1 (hu) CD38-ellenes antitestek a mielóma multiplex kezelésére
SG10201610317VA (en) Antibodies against cd38 for treatment of multiple myeloma